Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer: Data from the Madeline study

Dawn Michelle Odom; Maria Elizabeth Reynolds; Debanjali Mitra; D. Richardson; L Zhan; Maria Elizabeth Reynolds; Dawn Michelle Odom; Lynn McRoy; Debanjali Mitra; A. Zelnak; C. Jones

Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer

Data from the Madeline study

Richardson, D., Zhan, L., Reynolds, M., Odom, D., Mcroy, L., Mitra, D., Zelnak, A., & Jones, C. (2019). Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer: Data from the Madeline study. Value in Health, 22(S3), S527. https://doi.org/10.1016/j.jval.2019.09.657

Copy citation

Abstract

PCN465

To understand the value of the virtual community (VC) in a prospective multicenter study.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

publications@rti.org

RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.